Cell cycle and immune-related processes are significantly altered in chronic GVHD

Bone Marrow Transplantation

Volumn 41, Issue 12, 2008, Pages 1047-1057

  Oh, S J ^a,b   Cho, S B ^a   Park, S H ^a   Piao, C Z ^a   Kwon, S M ^a   Kim, I ^a   Yoon, S S ^a   Kim, B K ^a   Park, E K ^a,c   Kang, J J ^d   Yang, S J ^d   Lee, W J ^e   Yoo, C H ^e   Hwang, S ^e   Kim, S H ^e   Kim, J H ^a   Park, S ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Chung Ang University College of Medicine   (South Korea)

^d Macrogen Inc   (South Korea)

^e Digital Genomics Inc   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALNEXIN; CD3 ANTIGEN; LIPID; PHOSPHATIDYLSERINE SYNTHASE; PHOSPHORUS; VAV PROTEIN;

ACCURACY; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CELL CYCLE; CELLULAR IMMUNITY; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ALGORITHM; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; KIDNEY CARCINOMA; LIPOGENESIS; MALE; MICROARRAY ANALYSIS; MONONUCLEAR CELL; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; PHOSPHATE METABOLISM; PREDICTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UNINDEXED SEQUENCE; UPREGULATION;

CELL CYCLE; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 47949094437     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.37     Document Type: Article

References (41)

1. Lee SJ. New approaches for preventing and treating chronic graft-versus-host disease. Blood 2005; 105: 4200-4206.
2. Baird K, Pavletic SZ. Chronic graft versus host disease. Curr Opin Hematol 2006; 13: 426-435.
3. Socié G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late effects working committee of the international bone marrow transplant registry. N Engl J Med 1999; 341: 14-21.
4. Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215-233.
5. Hess AD. Modulation of graft-versus-host disease: Role of regulatory T lymphocytes. Biol Blood Marrow Transplant 2006; 12: 13-21.
6. Hess AD, Thoburn CJ. Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: Role of regulatory T cells. Biol Blood Marrow Transplant 2006; 12: 518-529.
7. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324: 667-674.
8. Kier P, Penner E, Bakos S, Kalhs P, Lechner K, Volc-Platzer B et al Autoantibodies in chronic GVHD: High prevalence of antinucleolar antibodies. Bone Marrow Transplant 1990; 6: 93-96.
9. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250-259.
10. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-537.
11. Segal E, Friedman N, Koller D, Regev A. A module map showing conditional activity of expression modules in cancer. Nat Genet 2004; 36 1090-1098.
12. Segal E, Friedman N, Kaminski N, Regev A, Koller D. From signatures to models: Understanding cancer using microarrays. Nat Genet 2005; 37 (Suppl): S38-S45.
13. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression Bioinformatics 2002; 18 (Suppl 1): S96-S104.
14. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19: 185-193.
15. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R et al. Missing value estimation methods for DNA microarrays. Bioinformatics 2001; 17: 520-525.
16. Chung HJ, Park CH, Han MR, Lee S, Ohn JH, Kim J et al. ArrayXPath II: Mapping and visualizing microarray gene-expression data with biomedical ontologies and integrated biological pathway resources using Scalable Vector Graphics. Nucleic Acids Res 2005; 33: W621-W626.
17. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-5121.
18. Dennis Jr G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC et al. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 2003; 4 (5): P3.
19. Goeman JJ, van de Geer SA, de Kort F, van Houwelingen HC. A global test for groups of genes: Testing association with a clinical outcome. Bioinformatics 2004; 20: 93-99.
20. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002; 99: 6567-6572.
21. Socié G, Mary JY, Lemann M, Daneshpouy M, Guardiola P, Meignin V et al. Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression. Blood 2004; 103: 50-57.
22. Cailhier JF, Laplante P, Hebert MJ. Endothelial apoptosis and chronic transplant vasculopathy: Recent results, novel mechanisms. Am J Transplant 2006; 6: 247-253.
23. Farag SS. Chronic graft-versus-host disease: Where do we go from here? Bone Marrow Transplant 2004; 33: 569-577.
24. Rouquette-Gally AM, Boyeldieu D, Prost AC, Gluckman E. Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients. Transplantation 1988; 46: 238-240.
25. Lister J, Messner H, Keystone E, Miller R, Fritzler MJ. Autoantibody analysis of patients with graft versus host disease. J Clin Lab Immunol 1987; 24: 19-23.
26. Canninga-van Dijk MR, van der Straaten HM, Fijnheer R, Sanders CJ, van den Tweel JG, Verdonck LF. Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease. Blood 2004; 104: 2603-2606.
27. Fernandez-Malave E, Wang N, Pulgar M, Schamel WW, Alarcon B, Terhorst C. Overlapping functions of human CD3delta and mouse CD3gamma in alphabeta T-cell development revealed in a humanized CD3gamma-mouse. Blood 2006; 108: 3420-3427.
28. Perez-Simon JA, Sanchez-Abarca I, Diez-Campelo M, Caballero D, San Miguel J. Chronic graft-versus-host disease: Pathogenesis and clinical management. Drugs 2006; 66: 1041-1057.
29. Ishikawa S, Sato T, Abe M, Nagai S, Onai N, Yoneyama H et al. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by Cl1b + CDl1c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J Exp Med 2001; 193: 1393-1402.
30. Shi K, Hayashida K, Kaneko M, Hashimoto J, Tomita T, Lipsky PE et al Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol 2001; 166: 650-655.
31. Abad C, Juarranz Y, Martinez C, Arranz A, Rosignoli F, García-Gómez M et al. cDNA array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: Homeostatic role of VIP. Inflamm Bowel Dis 2005; 11 674-684.
32. Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum 2005; 52: 1534-1544.
33. Le Panse R, Cizeron-Clairac G, Bismuth J, Berrih-Aknin S. Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia. J Immunol 2006; 177: 7868-7879.
34. Zheng Y, Kong Y, Goetzl EJ. Lysophosphatidic acid receptor-selective effects on Jurkat T cell migration through a Matrigel model basement membrane. J Immunol 2001; 166: 2317-2322.
35. Gizard F, Robillard R, Barbier O, Quatannens B, Faucompré A, Révillion F et al. TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1. Mol Cell Biol 2005; 25: 4335-4348.
36. Gilman AL, Serody J. Diagnosis and treatment of chronic graft-versus-host disease. Semin Hematol 2006; 43: 70-80.
37. Arbogast A, Boutet S, Phelouzat MA, Plastre O, Quadri R, Proust JJ. Failure of T lymphocytes from elderly humans to enter the cell cycle is associated with low Cdk6 activity and impaired phosphorylation of Rb protein. Cell Immunol 1999; 197: 46-54.
38. Rudd CE. Cell cycle 'check points' T cell anergy. Nat Immunol 2006; 7: 1130-1132.
39. Halin C, Scimone ML, Bonasio R, Gauguet JM, Mempel TR, Quackenbush E et al. The SIP-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed SIP1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches. Blood 2005; 106: 1314-1322.
40. Youn HD, Chatila TA, Liu JO. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J 2000; 19: 4323-4331.
41. Kansu E. The pathophysiology of chronic graft-versus-host disease. Int J Hematol 2004; 79: 209-215.